Discover
LTRN
Lantern Pharma Inc.
4.02
2 x 3.10
2 x 5.10
bid
ask
-
0.15
3.60%
2 @ 04:00 PM
4.02 +0.00 (0.00%)
| Ytd | 32.67% | |
| 1y | 27.62% |
3.95
day range
4.34
1.11
52 week range
5.74
| Open | 4.08 | Prev Close | 4.17 | Low | 3.95 | High | 4.34 | Mkt Cap | 51.29M |
| Vol | 104.16K | Avg Vol | 283.78K | EPS | -1.45 | P/E | N/A | Forward P/E | -1.50 |
| Beta | 1.57 | Short Ratio | 4.74 | Inst. Own | 24.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 3.18 | 200-d Avg | 3.22 | 1yr Est | 20.50 |
| Income Statement | |||
| Operating Expenses | 3.41M | ||
| Research and Development Expense | 1.72M | ||
| Selling, General and Administrative Expense | 1.68M | ||
| Operating Income | -3.41M | ||
| Net Income | -3.33M | ||
| Net Income Common Stock | -3.33M | ||
| Net Income Common Stock (USD) | -3.33M | ||
| Consolidated Income | -3.33M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -3.33M | ||
| Earning Before Interest & Taxes (USD) | -3.33M | ||
| Weighted Average Shares | 11.25M | ||
| Weighted Average Shares Diluted | 11.25M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.92M | ||
| Cash and Equivalents (USD) | 4.92M | ||
| Investments | 1.41M | ||
| Investments Current | 1.41M | ||
| Current Assets | 7.06M | ||
| Property, Plant & Equipment Net | 84.89K | ||
| Total Assets | 7.22M | ||
| Debt Current | 59.08K | ||
| Total Debt | 59.08K | ||
| Current Liabilities | 3.78M | ||
| Total Liabilities | 3.78M | ||
| Accumulated Retained Earnings (Deficit) | -96.47M | ||
| Accumulated Other Comprehensive Income | -35.64K | ||
| Shareholders Equity | 3.45M | ||
| Shareholders Equity (USD) | 3.45M | ||
| Assets Non-Current | 165.81K | ||
| Total Debt (USD) | 59.08K | ||
| Trade and Non-Trade Payables | 3.72M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.58K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 494.96K | ||
| Net Cash Flow from Investing | 4.25M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.25M | ||
| Net Cash Flow from Operations | -3.77M | ||
| Effect of Exchange Rate Changes on Cash | 17.59K | ||
| Share Based Compensation | 262.92K | ||